ATMA CENA Psychedelic Healthcare Solutions (PHS), a collaborative effort between ATMA Journey Centers and Cena Life, has opened its Calgary clinic as well as a new location in Edmonton.
The network is set to expand with additional clinics, for offering psychedelic-assisted therapy (PaT), in London and Toronto, Ontario.
Go deeper with GlobalData
ATMA CENA’s new corporate clinics, located at 5555 Calgary Trail NW in Edmonton and 742 – 42nd Ave SE in Calgary, will offer a range of treatments.
These include repetitive transcranial magnetic stimulation (rTMS), ketamine-assisted therapy (KaT), and psilocybin and MDMA-assisted therapy through the Special Access Program (SAP), complemented by various other psychological counselling services.
The Calgary and London locations will also be research hubs for clinical trials and offer in-person training opportunities.
ATMA CENA PHS is creating positions for independent therapists to integrate PaT into their practices.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAccording to the company, its clinics network adheres to Alberta’s Psychedelic Drug Treatment Service Standards and the College of Physicians and Surgeons of Alberta Accreditation Programme.
ATMA CENA PHS is further extending its network by inviting existing mental health practices to join as member clinics, providing them with guidance, support, and referrals while allowing them to maintain their independent operations.
The company said it has already secured nine letters of intent from clinics across Canada and is in the process of selecting members.
Updates on network member clinic locations will be provided to ensure therapists, practitioners, and patients are aware of the services available.
ATMA CENA PHS CEO co-founder and Reverdi Darda said: “With continually emerging evidence and the coming of regulations and accreditation standards across the provinces, provider organisations must be prepared to act promptly and comprehensively to meet high level and nuanced healthcare standards in a new and innovative industry.”
With MDMA-assisted therapy anticipated to become legal by fall 2024, ATMA CENA PHS is poised to assist clinics in adopting licensing and regulatory standards, following Alberta’s lead.
The network is said to be instrumental in preparing clinics for the operational delivery of MDMA therapy across Canada.
